Abortion is Health Care Everywhere Act of 2026

-HR 10600, S 5565-Abortion is Healthcare Everywhere Act- Met with Rep. Schakowsky and Sen. Booker staff on bill reintroduction, reviewed text, emails to House and Senate for cosponsors, social media content development and engagement in support of bill re-introduction.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; implementation of Sec. 6501 of P.L. 119-75, Preventing Maternal Deaths Reauthorization Act; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 7973, Momnibus Act H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9090/S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act; H.R. 10600, Abortion is Health Care Everywhere Act; S. ____, Know Your Risk Act; S. 3254/H.R. 6238, NIH IMPROVE Act; H.R. 9946, Equity in STI Testing Act; H.R. 3387, No Surprise Bills for New Moms Act; H.R. 9842, State Offices of Womens Health Support and Expansion Act; H.R. 2028/S. 942, REDI Act; H.R. 5536, HEADACHE Act; H.Res.739/S.Res.401, National Stillbirth Prevention & Awareness Day Resolution; S. ____, Jeanette Acosta Invest in Womens Health Act; HR.____ /S. 5554, Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act; H.R. ____, Improving Access to WIC Act; H.R. ____/S. ____, Support Through Loss Act; H.R. 6468/S. 5232, Rural Residency Planning and Development Act; H.R. _____/S. 4445, Right to IVF Act; S. 4494, maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); inclusion of pregnant and lactating women in clinical trials (general); NIH/NICHD womens health research (general); clinical research workforce development (general); access to fertility services and treatments (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); OMB Regulation for Federal Financial Assistance (OMB-2026-0034-0001); estradiol patch shortage (general); menopause education (general); risk-reducing salpingectomy (general).

Support the Equal Access to Abortion Coverage in Health Insurance (EACH) Act (HR 4611/S 2377) Support the Global Health, Empowerment, and Rights Act (HR 764/S 280) Support the Access to Reproductive Care for Servicemembers Act (HR 1742/S 275) Support the Right to Contraception Act (HR 999/S 422) Support the Right to IVF Act Support the Convenient Contraception Act (HR 2529/S 1239) Support the MARCH Act for Military Servicemembers Act (HR 3969/S 4574) Support the Protecting Human Rights and Public Health in Foreign Assistance Act (HR 8582/S 4426) Support the Right to IVF Act (S 5108/HR 9941) Support the Reproductive Health Care Accessibility Act of 2026 (HR 8829/S 4540) Support the Resolution Reaffirming that Mifepristone is Safe and Effective (H Res 1285/S Res 732) Support the Freedom to Travel for Health Care Act (S 4701) Support the Let Doctors Provide Reproductive Health Care Act (S 4879) Support the SAFE Training for OB-GYNs Act (HR 9441) Support the SAFER Health Act (HR 9470/S 4920) Support the Right to Contraception Act (HR 999/S 422) Support the Expressing Support for Reproductive Justice on the 250th Anniversary of the United States of America (H Res 1428) Support the Affordability is Access Act (HR 10597/S 5539) Support the Abortion is Health Care Everywhere Act (HR 10600/S 5565)

Client expense: $10,000 · Firm income: Not reported